1.7 |
6.6 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
1.0 |
3.9 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
0.8 |
3.0 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
0.8 |
3.8 |
GO:0007614 |
short-term memory(GO:0007614) |
0.7 |
4.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.6 |
1.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
0.6 |
1.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.6 |
2.4 |
GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.6 |
1.2 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
0.6 |
2.3 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.6 |
1.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 |
2.1 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
0.5 |
1.5 |
GO:0002887 |
negative regulation of myeloid leukocyte mediated immunity(GO:0002887) heme oxidation(GO:0006788) smooth muscle hyperplasia(GO:0014806) muscle hyperplasia(GO:0014900) negative regulation of leukocyte degranulation(GO:0043301) |
0.5 |
3.0 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.5 |
2.4 |
GO:1901031 |
regulation of cellular response to oxidative stress(GO:1900407) regulation of response to reactive oxygen species(GO:1901031) regulation of response to oxidative stress(GO:1902882) |
0.4 |
1.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 |
3.0 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 |
1.7 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.4 |
3.8 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 |
1.6 |
GO:0034201 |
response to oleic acid(GO:0034201) |
0.4 |
1.2 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
0.4 |
1.6 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
0.4 |
0.4 |
GO:0015838 |
quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.4 |
3.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
0.3 |
3.5 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
0.3 |
1.0 |
GO:0032571 |
response to vitamin K(GO:0032571) |
0.3 |
1.0 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 |
2.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
0.3 |
3.1 |
GO:0031639 |
plasminogen activation(GO:0031639) |
0.3 |
1.3 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
0.3 |
1.0 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
0.3 |
1.9 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.3 |
0.6 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
0.3 |
0.9 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 |
0.9 |
GO:0071883 |
adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 |
1.6 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 |
3.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 |
0.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 |
0.8 |
GO:0045062 |
extrathymic T cell differentiation(GO:0033078) extrathymic T cell selection(GO:0045062) |
0.3 |
0.8 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.3 |
0.8 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
0.3 |
1.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
0.2 |
1.2 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 |
0.7 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.2 |
1.6 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.2 |
1.6 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
0.2 |
3.0 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.2 |
1.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
0.2 |
0.2 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 |
0.6 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.2 |
1.3 |
GO:0006562 |
proline catabolic process(GO:0006562) |
0.2 |
1.3 |
GO:0055093 |
response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.2 |
2.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
0.2 |
0.6 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
0.2 |
1.4 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 |
1.2 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
0.2 |
0.6 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
0.2 |
0.2 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
0.2 |
0.6 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
0.2 |
0.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
0.2 |
0.6 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
0.2 |
0.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
0.2 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 |
0.5 |
GO:2000096 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 |
0.4 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
0.2 |
0.5 |
GO:0021837 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
0.2 |
0.4 |
GO:0070813 |
cysteine biosynthetic process(GO:0019344) hydrogen sulfide metabolic process(GO:0070813) hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 |
0.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
0.2 |
0.2 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 |
2.5 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
0.2 |
0.5 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.2 |
0.3 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.2 |
1.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
0.2 |
1.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
0.2 |
1.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
0.2 |
0.8 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
0.2 |
1.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
0.2 |
0.5 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
0.2 |
1.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
0.2 |
0.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
0.2 |
0.2 |
GO:0034341 |
response to interferon-gamma(GO:0034341) |
0.2 |
0.6 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 |
1.6 |
GO:0097435 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.2 |
0.9 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
0.2 |
0.3 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
0.2 |
1.7 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 |
0.7 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 |
6.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.1 |
0.9 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
0.1 |
0.1 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 |
0.1 |
GO:2000095 |
regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 |
1.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
0.1 |
0.3 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
0.1 |
0.4 |
GO:0008218 |
bioluminescence(GO:0008218) |
0.1 |
1.3 |
GO:0008354 |
germ cell migration(GO:0008354) |
0.1 |
0.1 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
0.1 |
0.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 |
0.6 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 |
0.1 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
0.1 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
0.1 |
0.8 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
0.1 |
0.4 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
0.1 |
0.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
0.1 |
0.5 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 |
0.5 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
0.1 |
0.4 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 |
0.8 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 |
0.1 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 |
0.9 |
GO:0042483 |
negative regulation of odontogenesis(GO:0042483) |
0.1 |
0.4 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
0.1 |
0.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 |
0.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
0.1 |
0.4 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
0.1 |
1.0 |
GO:0039703 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 |
0.6 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 |
0.4 |
GO:0007412 |
axon target recognition(GO:0007412) |
0.1 |
0.9 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 |
0.8 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 |
1.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
0.1 |
0.4 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
0.1 |
0.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
0.1 |
0.5 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 |
2.9 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 |
2.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 |
0.8 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 |
0.6 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
0.1 |
2.6 |
GO:0051923 |
sulfation(GO:0051923) |
0.1 |
0.1 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
0.1 |
0.8 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
0.1 |
0.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
0.1 |
0.5 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
0.1 |
0.5 |
GO:0006925 |
inflammatory cell apoptotic process(GO:0006925) |
0.1 |
0.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
0.1 |
0.8 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
0.1 |
0.3 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 |
1.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
0.1 |
1.3 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 |
0.6 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
0.1 |
0.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
0.1 |
1.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
0.1 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
0.1 |
0.4 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
0.1 |
2.1 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
0.1 |
0.1 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
0.1 |
2.1 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 |
0.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
0.1 |
0.3 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
0.1 |
2.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 |
1.7 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 |
0.3 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.1 |
0.6 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 |
0.2 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
0.1 |
0.5 |
GO:0051917 |
regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.1 |
0.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
0.1 |
0.5 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 |
0.3 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
0.1 |
0.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
0.1 |
0.7 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 |
1.2 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.1 |
0.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
0.1 |
8.2 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
0.1 |
0.3 |
GO:0014040 |
regulation of Schwann cell differentiation(GO:0014038) positive regulation of Schwann cell differentiation(GO:0014040) |
0.1 |
1.3 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
0.1 |
0.2 |
GO:0070997 |
neuron death(GO:0070997) |
0.1 |
1.9 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
0.1 |
0.4 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
0.1 |
0.2 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
0.1 |
0.8 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 |
0.2 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 |
0.2 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
0.1 |
0.2 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 |
0.2 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
0.1 |
1.4 |
GO:0031000 |
response to caffeine(GO:0031000) |
0.1 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
0.1 |
0.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 |
0.3 |
GO:0032236 |
obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 |
0.2 |
GO:0051216 |
cartilage development(GO:0051216) |
0.1 |
0.5 |
GO:0001554 |
luteolysis(GO:0001554) |
0.1 |
0.5 |
GO:0010737 |
protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.1 |
0.5 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
0.1 |
1.8 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 |
5.8 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 |
0.1 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
0.1 |
0.2 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
0.1 |
2.2 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
0.1 |
0.4 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
0.1 |
0.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 |
0.2 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 |
2.0 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
0.1 |
0.7 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 |
0.4 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
0.1 |
0.1 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 |
0.1 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.1 |
0.4 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 |
0.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
0.1 |
0.4 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
0.1 |
0.2 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 |
0.8 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 |
0.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 |
0.4 |
GO:0001553 |
luteinization(GO:0001553) |
0.1 |
0.2 |
GO:0071529 |
cementum mineralization(GO:0071529) |
0.1 |
0.5 |
GO:0015886 |
heme transport(GO:0015886) |
0.1 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
0.1 |
0.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 |
0.2 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
0.1 |
0.5 |
GO:0019054 |
modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.1 |
0.3 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
0.1 |
1.9 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 |
0.7 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
0.1 |
0.3 |
GO:0009301 |
snRNA transcription(GO:0009301) |
0.1 |
0.3 |
GO:0016322 |
neuron remodeling(GO:0016322) |
0.1 |
0.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.1 |
0.2 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 |
2.0 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
0.1 |
0.8 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 |
0.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
0.1 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 |
0.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
0.1 |
1.5 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
0.1 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
0.1 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
0.1 |
0.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
0.1 |
0.2 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 |
0.1 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
0.1 |
0.2 |
GO:0048743 |
RNA folding(GO:0034337) DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) regulation of DNA methylation(GO:0044030) positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 |
1.4 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
0.1 |
0.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
0.1 |
0.6 |
GO:0040007 |
growth(GO:0040007) |
0.1 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.1 |
0.3 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
0.1 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
0.1 |
0.1 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
0.1 |
0.2 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
0.1 |
0.5 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
0.1 |
0.6 |
GO:0046697 |
decidualization(GO:0046697) |
0.1 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 |
0.1 |
GO:0033025 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 |
0.2 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 |
0.5 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
0.1 |
0.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 |
0.5 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 |
0.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
0.1 |
0.3 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
0.1 |
0.6 |
GO:0010038 |
response to metal ion(GO:0010038) |
0.1 |
0.1 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 |
1.1 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
0.1 |
0.2 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 |
0.1 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.1 |
0.3 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 |
0.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
0.1 |
0.1 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 |
0.4 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
0.1 |
0.4 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
0.1 |
0.4 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 |
0.2 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 |
0.6 |
GO:0032814 |
regulation of natural killer cell activation(GO:0032814) |
0.1 |
0.1 |
GO:0045844 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 |
0.1 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 |
0.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) carbohydrate mediated signaling(GO:0009756) |
0.1 |
0.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
0.1 |
0.2 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 |
0.3 |
GO:0051318 |
G1 phase(GO:0051318) |
0.0 |
0.2 |
GO:0006984 |
ER-nucleus signaling pathway(GO:0006984) |
0.0 |
0.0 |
GO:0035929 |
steroid hormone secretion(GO:0035929) |
0.0 |
0.1 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
0.0 |
0.1 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 |
0.5 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
0.0 |
0.2 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) positive regulation of type I interferon production(GO:0032481) interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) positive regulation of interferon-beta production(GO:0032728) |
0.0 |
0.2 |
GO:0051154 |
negative regulation of myotube differentiation(GO:0010832) negative regulation of striated muscle cell differentiation(GO:0051154) |
0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.0 |
0.5 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 |
0.0 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 |
1.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
0.0 |
0.1 |
GO:0035269 |
protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 |
0.6 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
0.0 |
0.0 |
GO:0031297 |
replication fork processing(GO:0031297) |
0.0 |
0.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
0.0 |
0.3 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 |
0.5 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
0.0 |
0.1 |
GO:0043543 |
protein acylation(GO:0043543) |
0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
0.0 |
0.1 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 |
0.0 |
GO:0015824 |
proline transport(GO:0015824) |
0.0 |
0.5 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
0.0 |
0.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
0.0 |
0.6 |
GO:0032456 |
endocytic recycling(GO:0032456) |
0.0 |
0.2 |
GO:0070192 |
synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 |
3.0 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
0.0 |
0.1 |
GO:0043049 |
otic placode formation(GO:0043049) |
0.0 |
0.3 |
GO:0006069 |
ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 |
0.0 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 |
0.4 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 |
0.0 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 |
0.1 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.0 |
0.1 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 |
0.2 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
0.0 |
0.2 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
0.0 |
0.7 |
GO:0050832 |
defense response to fungus(GO:0050832) |
0.0 |
0.5 |
GO:0051608 |
histamine transport(GO:0051608) |
0.0 |
0.9 |
GO:0048286 |
lung alveolus development(GO:0048286) |
0.0 |
0.6 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 |
0.1 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
0.0 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 |
0.2 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
0.0 |
0.2 |
GO:0015811 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 |
0.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
0.0 |
0.2 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
0.0 |
0.3 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 |
0.2 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
0.0 |
0.2 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
0.0 |
0.0 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 |
0.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.0 |
0.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
0.0 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
0.0 |
0.3 |
GO:0046618 |
drug export(GO:0046618) |
0.0 |
0.2 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
0.0 |
0.2 |
GO:0008038 |
neuron recognition(GO:0008038) |
0.0 |
0.7 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
0.0 |
0.0 |
GO:0048736 |
appendage development(GO:0048736) limb development(GO:0060173) |
0.0 |
0.1 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 |
0.2 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
0.0 |
0.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
0.0 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
0.0 |
0.2 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
0.0 |
0.1 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
0.0 |
0.4 |
GO:0006030 |
aminoglycan catabolic process(GO:0006026) chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 |
0.3 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
0.0 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
0.0 |
0.2 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
0.0 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
0.0 |
0.1 |
GO:0003079 |
obsolete positive regulation of natriuresis(GO:0003079) |
0.0 |
0.4 |
GO:0006783 |
porphyrin-containing compound biosynthetic process(GO:0006779) heme biosynthetic process(GO:0006783) tetrapyrrole biosynthetic process(GO:0033014) |
0.0 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
0.0 |
0.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.0 |
1.0 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 |
0.0 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 |
0.1 |
GO:0010834 |
obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 |
0.2 |
GO:0019985 |
translesion synthesis(GO:0019985) |
0.0 |
0.0 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
0.0 |
0.2 |
GO:0002634 |
regulation of germinal center formation(GO:0002634) |
0.0 |
0.1 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
0.0 |
0.5 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 |
0.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 |
0.1 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 |
0.2 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 |
0.1 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
0.0 |
0.2 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 |
0.4 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
0.0 |
0.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.0 |
0.2 |
GO:0018101 |
protein citrullination(GO:0018101) |
0.0 |
0.2 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 |
0.4 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
0.0 |
0.0 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
0.0 |
0.1 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 |
0.6 |
GO:0008347 |
glial cell migration(GO:0008347) |
0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.0 |
0.1 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 |
0.1 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 |
0.1 |
GO:1902743 |
regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.0 |
0.1 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
0.0 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
0.0 |
0.2 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
0.0 |
0.1 |
GO:0006154 |
adenosine catabolic process(GO:0006154) |
0.0 |
0.1 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 |
0.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
0.0 |
0.1 |
GO:0002645 |
regulation of tolerance induction(GO:0002643) positive regulation of tolerance induction(GO:0002645) |
0.0 |
0.0 |
GO:0051891 |
positive regulation of cardioblast differentiation(GO:0051891) negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 |
0.0 |
GO:0052510 |
modulation by symbiont of host defense response(GO:0052031) pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 |
0.2 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 |
0.6 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
0.0 |
1.8 |
GO:0008064 |
regulation of actin polymerization or depolymerization(GO:0008064) |
0.0 |
0.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
0.0 |
0.2 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) ribonucleoprotein complex disassembly(GO:0032988) |
0.0 |
0.1 |
GO:0042335 |
cuticle development(GO:0042335) |
0.0 |
0.8 |
GO:0030183 |
B cell differentiation(GO:0030183) |
0.0 |
0.1 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 |
0.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 |
0.1 |
GO:0000902 |
cell morphogenesis(GO:0000902) |
0.0 |
0.0 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
0.0 |
0.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 |
0.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) histone lysine methylation(GO:0034968) |
0.0 |
0.5 |
GO:0050848 |
regulation of calcium-mediated signaling(GO:0050848) |
0.0 |
0.1 |
GO:0060969 |
negative regulation of gene silencing(GO:0060969) |
0.0 |
0.5 |
GO:0046324 |
regulation of glucose import(GO:0046324) |
0.0 |
0.0 |
GO:0055062 |
phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 |
0.1 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
0.0 |
0.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
0.0 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
0.0 |
0.4 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
0.0 |
0.5 |
GO:0007602 |
phototransduction(GO:0007602) |
0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
0.0 |
0.6 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
0.0 |
0.4 |
GO:0007030 |
Golgi organization(GO:0007030) |
0.0 |
3.1 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
0.0 |
0.1 |
GO:1901998 |
tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 |
0.1 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
0.0 |
0.1 |
GO:0003407 |
neural retina development(GO:0003407) |
0.0 |
0.1 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
0.0 |
0.0 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 |
0.0 |
GO:0021938 |
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 |
0.2 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 |
0.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
0.0 |
0.2 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
0.0 |
0.1 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
0.0 |
0.3 |
GO:1902603 |
carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) carnitine transmembrane transport(GO:1902603) |
0.0 |
0.3 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 |
0.1 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
0.0 |
0.3 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 |
0.1 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
0.0 |
2.7 |
GO:0006814 |
sodium ion transport(GO:0006814) |
0.0 |
0.0 |
GO:0010720 |
positive regulation of cell development(GO:0010720) |
0.0 |
0.0 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
0.0 |
0.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 |
0.1 |
GO:0042762 |
regulation of sulfur metabolic process(GO:0042762) |
0.0 |
0.1 |
GO:0051272 |
positive regulation of cell migration(GO:0030335) positive regulation of cellular component movement(GO:0051272) positive regulation of cell motility(GO:2000147) |
0.0 |
0.1 |
GO:0051823 |
hindbrain radial glia guided cell migration(GO:0021932) regulation of synapse structural plasticity(GO:0051823) |
0.0 |
1.7 |
GO:0007565 |
female pregnancy(GO:0007565) |
0.0 |
0.0 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
0.0 |
0.5 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
0.0 |
0.2 |
GO:0046503 |
glycerolipid catabolic process(GO:0046503) |
0.0 |
0.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
0.0 |
0.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.0 |
0.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 |
0.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.0 |
1.7 |
GO:0048511 |
rhythmic process(GO:0048511) |
0.0 |
0.0 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
0.0 |
0.1 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 |
0.0 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
0.0 |
0.1 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 |
0.1 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
0.0 |
0.6 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
0.0 |
3.4 |
GO:0006936 |
muscle contraction(GO:0006936) |
0.0 |
0.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
0.0 |
0.4 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
0.0 |
0.1 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.0 |
2.5 |
GO:0006415 |
translational termination(GO:0006415) |
0.0 |
0.1 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
0.0 |
0.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
0.0 |
0.1 |
GO:1902591 |
vesicle coating(GO:0006901) single-organism membrane budding(GO:1902591) |
0.0 |
0.1 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
0.0 |
0.1 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
0.0 |
0.1 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
0.0 |
0.2 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
0.0 |
0.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
0.0 |
0.0 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 |
0.3 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
0.0 |
0.3 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
0.0 |
0.2 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
0.0 |
0.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
0.0 |
0.1 |
GO:0007567 |
parturition(GO:0007567) |
0.0 |
0.0 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 |
0.2 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 |
0.1 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 |
0.0 |
GO:0002384 |
organ or tissue specific immune response(GO:0002251) hepatic immune response(GO:0002384) |
0.0 |
0.1 |
GO:0045069 |
regulation of viral genome replication(GO:0045069) |
0.0 |
0.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 |
0.1 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
0.0 |
0.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
0.0 |
0.0 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
0.0 |
0.1 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 |
0.0 |
GO:0000018 |
regulation of DNA recombination(GO:0000018) |
0.0 |
0.1 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
0.0 |
0.3 |
GO:0055088 |
lipid homeostasis(GO:0055088) |
0.0 |
0.1 |
GO:0045007 |
depurination(GO:0045007) |
0.0 |
0.5 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
0.0 |
1.0 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
0.0 |
0.0 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
0.0 |
0.1 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 |
0.1 |
GO:0035082 |
axoneme assembly(GO:0035082) |
0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
0.0 |
0.3 |
GO:0007338 |
single fertilization(GO:0007338) |
0.0 |
0.1 |
GO:0009650 |
UV protection(GO:0009650) |
0.0 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.0 |
0.0 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 |
0.0 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
0.0 |
0.4 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
0.0 |
0.9 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.0 |
0.1 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
0.0 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |